Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Paul Franks

Paul Franks

Principal investigator

Paul Franks

Age at Menarche and Type 2 Diabetes Risk The EPIC-InterAct study

Author

  • Cathy E. Elks
  • Ken K. Ong
  • Robert A. Scott
  • Yvonne T. van der Schouw
  • Judith S. Brand
  • Petra A. Wark
  • Pilar Amiano
  • Beverley Balkau
  • Aurelio Barricarte
  • Heiner Boeing
  • Ana Fonseca-Nunes
  • Paul Franks
  • Sara Grioni
  • Jytte Halkjaer
  • Rudolf Kaaks
  • Timothy J. Key
  • Kay Tee Khaw
  • Amalia Mattiello
  • Peter Nilsson
  • Kim Overvad
  • Domenico Palli
  • J. Ramon Quiros
  • Sabina Rinaldi
  • Olov Rolandsson
  • Isabelle Romieu
  • Carlotta Sacerdote
  • Maria-Jose Sanchez
  • Annemieke M. W. Spijkerman
  • Anne Tjonneland
  • Maria-Jose Tormo
  • Rosario Tumino
  • L. Van der A. Daphne
  • Nita G. Forouhi
  • Stephen J. Sharp
  • Claudia Langenberg
  • Elio Riboli
  • Nicholas J. Wareham

Summary, in English

OBJECTIVEYounger age at menarche, a marker of pubertal timing in girls, is associated with higher risk of later type 2 diabetes. We aimed to confirm this association and to examine whether it is explained by adiposity.RESEARCH DESIGN AND METHODSThe prospective European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study consists of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 individuals from 26 research centers across eight European countries. We tested the association between age at menarche and incident type 2 diabetes using Prentice-weighted Cox regression in 15,168 women (n = 5,995 cases). Models were adjusted in a sequential manner for potential confounding and mediating factors, including adult BMI.RESULTSMean menarcheal age ranged from 12.6 to 13.6 years across InterAct countries. Each year later menarche was associated with 0.32 kg/m(2) lower adult BMI. Women in the earliest menarche quintile (8-11 years, n = 2,418) had 70% higher incidence of type 2 diabetes compared with those in the middle quintile (13 years, n = 3,634), adjusting for age at recruitment, research center, and a range of lifestyle and reproductive factors (hazard ratio [HR], 1.70; 95% CI, 1.49-1.94; P < 0.001). Adjustment for BMI partially attenuated this association (HR, 1.42; 95% CI, 1.18-1.71; P < 0.001). Later menarche beyond the median age was not protective against type 2 diabetes.CONCLUSIONSWomen with history of early menarche have higher risk of type 2 diabetes in adulthood. Less than half of this association appears to be mediated by higher adult BMI, suggesting that early pubertal development also may directly increase type 2 diabetes risk.

Department/s

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2013

Language

English

Pages

3526-3534

Publication/Series

Diabetes Care

Volume

36

Issue

11

Document type

Journal article

Publisher

American Diabetes Association

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology

ISBN/ISSN/Other

  • ISSN: 1935-5548